A detailed history of Exor Capital LLP transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Exor Capital LLP holds 89,232 shares of LNTH stock, worth $7.76 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
89,232
Previous 55,274 61.44%
Holding current value
$7.76 Million
Previous $6.07 Million 31.59%
% of portfolio
0.23%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$76.22 - $116.71 $2.59 Million - $3.96 Million
33,958 Added 61.44%
89,232 $7.98 Million
Q3 2024

Nov 13, 2024

BUY
$77.7 - $123.62 $4.29 Million - $6.83 Million
55,274 New
55,274 $6.07 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.97B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Exor Capital LLP Portfolio

Follow Exor Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exor Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Exor Capital LLP with notifications on news.